MT
Marcella Tazzari
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori, IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori, Karolinska Institutet, University of Ferrara
Research areas: Medicine · Oncology · Cancer Immunotherapy and Biomarkers · Immunotherapy and Immune Responses · Sarcoma Diagnosis and Treatment
0000-0002-8112-1773
Employment
-
IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori Coordinator of the Immune Microenvironment Adaptive and Vaccine Approaches2021 - Present
-
IRCCS Istituto Romagnolo per lo Studio dei Tumori Dino Amadori Post Doctoral Research Fellow2018 - 2020
-
Radboudumc Postdoctoral Researcher2016 - 2017
-
Fondazione IRCCS Istituto Nazionale dei Tumori Post-doctoral Research Fellow2014 - 2016
-
Fondazione IRCCS Istituto Nazionale dei Tumori PhD Student2011 - 2014
-
Fondazione IRCCS Istituto Nazionale dei Tumori Graduate Fellow2009 - 2010
Education
-
Karolinska Institutet Master-Thesis Student2008 - 2009
-
Universita degli Studi di Ferrara Undergraduate Student2003 - 2009
Projects & Funding
-
Unveiling the function of tertiary lymphoid structures and associated CXCL13 to enhance immunotherapy in solid tumors Italian Association for Cancer Research
Publications (37)
- Vaccine-expanded plasmablast-like B cells are associated with response to dendritic cell therapy in metastatic melanoma Save
- Comparative analysis of library preparation approaches for FFPE gene expression profiling and related recommendations. Save
- Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability. Save
- Adjuvant dendritic cell-based immunotherapy in melanoma: insights into immune cell dynamics and clinical evidence from a phase II trial. Save
- Comparative Evaluation of Commercial, Freely Available, and Open-Source Tools for Single-Cell Analysis Within Freehand-Defined Histological Brightfield Image Regions of Interest Save
- Highlighting recent achievements to advance more effective cancer immunotherapy. Save
- Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE). Save
- First step results from a phase II study of a dendritic cell vaccine in glioblastoma patients (CombiG-vax). Save
- Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in advanced therapy medicinal products. Save
- Data Science for Health Image Alignment: A User-Friendly Open-Source ImageJ/Fiji Plugin for Aligning Multimodality/Immunohistochemistry/Immunofluorescence 2D Microscopy Images Save
- Insights into an Autologous Dendritic Cells Vaccine for Glioblastoma: First Step Results from a Phase II Study (CombiG-Vax) Save
- Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series. Save
- Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival Save
- Circulating hsa-miR-5096 predicts 18F-FDG PET/CT positivity and modulates somatostatin receptor 2 expression: a novel miR-based assay for pancreatic neuroendocrine tumors. Save
- Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center Save
- Immunotherapy in soft tissue sarcoma: current evidence and future perspectives in a variegated family of different tumor. Save
- Molecular Determinants of Soft Tissue Sarcoma Immunity: Targets for Immune Intervention Save
- Effects of a Diet Based on Foods from Symbiotic Agriculture on the Gut Microbiota of Subjects at Risk for Metabolic Syndrome. Save
- Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients Save
- CAR T cells targeting options in the fight against multiple myeloma. Save